Savitha Krishnan, MD
Undefined Physician Type (Specify) · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Krishnan’s office at (650) 934-7520 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A71453 · Current
Licensed to practise in California · since 2000 · expires 2027-06-30 · University of Michigan Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$427,262
Medicare paid this office $427,262 for 526 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Botox | 78 | $99,635 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 78 | $55,824 | $396 |
| Surgical repair of vaginal defect using an endoscope | 40 | $33,528 | $838 |
| Return visit (30+ min) | 211 | $31,391 | $117 |
| New patient visit (45+ min) | 211 | $30,361 | $144 |
See all 22 services
| Botox | 78 | $99,635 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 78 | $55,824 | $396 |
| Surgical repair of vaginal defect using an endoscope | 40 | $33,528 | $838 |
| Return visit (30+ min) | 211 | $31,391 | $117 |
| New patient visit (45+ min) | 211 | $30,361 | $144 |
| Creation of sling around urethra in female to control leakage | 65 | $28,387 | $437 |
| Insertion of lower leg neurostimulator electrode | 44 | $26,960 | $124 |
| Insertion of sacral nerve neurostimulator electrode array | 22 | $24,769 | $1,126 |
| Long return visit (40+ min) | 86 | $15,732 | $164 |
| Repair of herniated rectum into vaginal wall | 39 | $11,473 | $294 |
| Insertion of sacral nerve neurostimulator electrode array | 33 | $9,005 | $273 |
| Simple bladder irrigation and/or instillation | 81 | $5,826 | $40 |
| Partial removal of uterus, tubes, and/or ovaries with retention of cervix using an endoscope, 250.0 g or less | 15 | $5,666 | $378 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 30 | $5,035 | $168 |
| New patient visit (60+ min) | 17 | $3,477 | $205 |
| Removal of uterine tubes and ovaries | 11 | $3,355 | $305 |
| Suture closure of vagina and vaginal opening | 11 | $2,723 | $248 |
| Short return visit (20+ min) | 20 | $1,593 | $80 |
| Ultrasound measurement of bladder capacity after voiding | 103 | $1,303 | $12 |
| Insertion of temporary bladder tube | 23 | $1,059 | $44 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 29 | $1,033 | $36 |
| Imaging guidance for procedure, 60 minutes or less | 28 | $380 | $13 |
Procedures Medicare counted
| Removal of the uterus | 38 | More than 98% of doctors who do this |
Who their Medicare patients are
526 Original Medicare patients in 2024. Average age 77 · Also on Medicaid 9% · Health risk score 0.84. At or below the middle of the specialty; the typical undefined physician type clinician is at 1.67.
Conditions among them: High blood pressure 60% · Diabetes 20% · Depression 20% · Coronary heart disease 15% · Chronic kidney disease 15% · Cancer 15% · Atrial fibrillation 13% · Heart failure 7% · COPD 6% · Dementia 5% · Stroke 3%.
The office billed $1,901,148, Medicare allowed $546,832 and paid $427,262; for 22,292 services of 58 kinds; $101,308 of it was for drugs given in the office and $325,954 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 526 | 22,292 | 77 | 0.84 | $1,901,148 | $427,262 |
| 2023 | 560 | 21,395 | 77 | 0.93 | $1,760,184 | $424,743 |
| 2022 | 496 | 17,576 | 76 | 0.90 | $1,621,006 | $386,073 |
| 2021 | 494 | 16,887 | 76 | 0.91 | $1,409,981 | $373,110 |
| 2020 | 398 | 14,179 | 76 | 0.99 | $1,008,843 | $264,089 |
| 2019 | 475 | 22,139 | 76 | 0.91 | $1,246,799 | $338,819 |
| 2018 | 506 | 18,237 | 75 | 0.91 | $1,552,178 | $406,704 |
| 2017 | 378 | 8,833 | 75 | 0.92 | $1,162,772 | $284,087 |
| 2016 | 319 | 3,266 | 75 | 0.98 | $825,003 | $202,796 |
| 2015 | 221 | 1,141 | 74 | 1.06 | $586,766 | $140,229 |
| 2014 | 132 | 873 | 74 | 0.83 | $487,146 | $113,441 |
| 2013 | 57 | 189 | 72 | 0.80 | $103,002 | $22,182 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 20 services
| Botox | 73 | $95,240 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 73 | $55,413 | $404 |
| Return visit (30+ min) | 310 | $50,870 | $115 |
| Surgical repair of vaginal defect using an endoscope | 38 | $32,684 | $860 |
| Insertion of sacral nerve neurostimulator electrode array | 19 | $21,982 | $1,157 |
| Insertion of lower leg neurostimulator electrode | 55 | $21,848 | $123 |
| Long return visit (40+ min) | 106 | $20,388 | $170 |
| Creation of sling around urethra in female to control leakage | 46 | $19,272 | $419 |
| New patient visit (45+ min) | 120 | $18,006 | $150 |
| Repair of herniated rectum into vaginal wall | 37 | $12,036 | $317 |
| Insertion of sacral nerve neurostimulator electrode array | 33 | $9,607 | $283 |
| New patient visit (60+ min) | 40 | $7,873 | $197 |
| Short return visit (20+ min) | 70 | $6,229 | $78 |
| Partial removal of uterus, tubes, and/or ovaries with retention of cervix using an endoscope, 250.0 g or less | 15 | $5,804 | $387 |
| Simple bladder irrigation and/or instillation | 74 | $5,574 | $41 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 32 | $3,219 | $101 |
| Insertion of temporary bladder tube | 40 | $1,838 | $44 |
| Ultrasound measurement of bladder capacity after voiding | 68 | $760 | $11 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 21 | $641 | $25 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 11 | $438 | $37 |
2022: 27 services
| Botox | 59 | $77,383 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 60 | $45,405 | $413 |
| Insertion of sacral nerve neurostimulator electrode array | 29 | $35,039 | $1,208 |
| Return visit (30+ min) | 209 | $30,623 | $116 |
| Insertion of lower leg neurostimulator electrode | 75 | $26,350 | $127 |
| Surgical repair of vaginal defect using an endoscope | 26 | $22,104 | $850 |
| Creation of sling around urethra in female to control leakage | 50 | $22,025 | $441 |
| New patient visit (45+ min) | 139 | $19,524 | $140 |
| Insertion of sacral nerve neurostimulator electrode | 31 | $18,299 | $590 |
| Repair of herniated rectum into vaginal wall | 31 | $9,658 | $312 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 13 | $7,995 | $615 |
| Diagnostic exam of bladder and urethra using an endoscope | 27 | $7,033 | $251 |
| Partial removal of uterus, tubes, and/or ovaries with retention of cervix using an endoscope, 250.0 g or less | 15 | $5,558 | $371 |
| Short return visit (20+ min) | 59 | $5,517 | $84 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 50 | $5,247 | $103 |
| Insertion of sacral nerve neurostimulator electrode array | 19 | $5,237 | $276 |
| Simple bladder irrigation and/or instillation | 58 | $4,338 | $41 |
| New patient visit (60+ min) | 21 | $4,217 | $201 |
| New patient visit (30+ min) | 37 | $3,659 | $99 |
| Long return visit (40+ min) | 20 | $3,134 | $157 |
| Suture closure of vagina and vaginal opening | 11 | $2,355 | $214 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 27 | $1,029 | $37 |
| Ultrasound measurement of bladder capacity after voiding | 66 | $711 | $11 |
| Imaging guidance for procedure, 60 minutes or less | 38 | $567 | $14 |
| Insertion of temporary bladder tube | 13 | $536 | $41 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $408 | $27 |
| Unclassified drugs | 46 | $330 | None |
2021: 24 services
| Botox | 61 | $72,964 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 61 | $42,358 | $407 |
| Return visit (30+ min) | 228 | $39,289 | $118 |
| Insertion of lower leg neurostimulator electrode | 61 | $27,369 | $134 |
| Surgical repair of vaginal defect using an endoscope | 25 | $22,503 | $900 |
| Insertion of sacral nerve neurostimulator electrode array | 17 | $20,187 | $1,187 |
| New patient visit (45+ min) | 132 | $18,221 | $138 |
| Insertion of sacral nerve neurostimulator electrode | 28 | $17,586 | $586 |
| Creation of sling around urethra in female to control leakage | 36 | $16,570 | $460 |
| Repair of herniated rectum into vaginal wall | 37 | $13,229 | $348 |
| Short return visit (20+ min) | 117 | $12,566 | $84 |
| Partial removal of uterus, tubes, and/or ovaries with retention of cervix using an endoscope, 250.0 g or less | 18 | $7,030 | $391 |
| Long return visit (40+ min) | 28 | $4,749 | $164 |
| Simple bladder irrigation and/or instillation | 59 | $4,413 | $45 |
| New patient visit (30+ min) | 40 | $4,118 | $103 |
| Diagnostic exam of bladder and urethra using an endoscope | 15 | $3,754 | $235 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 27 | $2,677 | $99 |
| New patient visit (60+ min) | 13 | $2,391 | $184 |
| Insertion of temporary bladder tube | 43 | $2,058 | $44 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 26 | $2,053 | $55 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 21 | $796 | $38 |
| Unclassified drugs | 58 | $480 | None |
| Imaging guidance for procedure, 60 minutes or less | 32 | $442 | $14 |
| Ultrasound measurement of bladder capacity after voiding | 16 | $183 | $11 |
2020: 17 services
| Botox | 56 | $62,411 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 57 | $32,484 | $373 |
| Return visit (30+ min) | 193 | $28,672 | $101 |
| Creation of sling around urethra in female to control leakage | 38 | $19,774 | $520 |
| Surgical repair of vaginal defect using an endoscope | 17 | $15,638 | $920 |
| Insertion of sacral nerve neurostimulator electrode array | 15 | $14,540 | $969 |
| New patient visit (30+ min) | 145 | $13,571 | $94 |
| Insertion of lower leg neurostimulator electrode | 41 | $10,938 | $135 |
| Repair of herniated rectum into vaginal wall | 24 | $8,941 | $373 |
| Insertion of sacral nerve neurostimulator electrode | 11 | $6,881 | $626 |
| Partial removal of uterus, tubes, and/or ovaries with retention of cervix using an endoscope, 250.0 g or less | 12 | $4,680 | $390 |
| Short return visit (20+ min) | 45 | $3,936 | $74 |
| Simple bladder irrigation and/or instillation | 51 | $2,846 | $40 |
| Insertion of temporary bladder tube | 66 | $2,781 | $42 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 13 | $1,328 | $102 |
| Unclassified drugs | 57 | $406 | None |
| Imaging guidance for procedure, 60 minutes or less | 14 | $208 | $14 |
2019: 19 services
| Botox | 82 | $95,675 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 82 | $50,845 | $339 |
| Insertion of lower leg neurostimulator electrode | 81 | $36,702 | $122 |
| Return visit (30+ min) | 201 | $28,399 | $101 |
| Surgical repair of vaginal defect using an endoscope | 28 | $24,713 | $883 |
| Creation of sling around urethra in female to control leakage | 38 | $18,477 | $486 |
| New patient visit (30+ min) | 119 | $11,817 | $99 |
| Short return visit (20+ min) | 118 | $9,995 | $67 |
| Partial removal of uterus, tubes, and/or ovaries with retention of cervix using an endoscope, 250.0 g or less | 17 | $6,750 | $397 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 12 | $6,532 | $544 |
| Repair of herniated rectum into vaginal wall | 18 | $5,923 | $329 |
| Insertion of temporary bladder tube | 103 | $4,600 | $43 |
| Simple bladder irrigation and/or instillation | 66 | $4,005 | $42 |
| New patient visit (45+ min) | 12 | $1,579 | $132 |
| New patient visit (15+ min) | 23 | $1,561 | $68 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 11 | $820 | $55 |
| Unclassified drugs | 63 | $418 | None |
| Electronic assessment of bladder emptying | 11 | $85 | $8 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 21 | $4 | None |
2018: 19 services
| Insertion of lower leg neurostimulator electrode | 66 | $91,509 | $131 |
| Botox | 71 | $76,670 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 71 | $36,744 | $309 |
| Surgical repair of vaginal defect using an endoscope | 38 | $31,687 | $834 |
| Creation of sling around urethra in female to control leakage | 55 | $22,701 | $413 |
| New patient visit (30+ min) | 235 | $21,764 | $93 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 37 | $19,653 | $531 |
| Return visit (30+ min) | 121 | $13,820 | $99 |
| Insertion of temporary bladder tube | 250 | $11,390 | $44 |
| Repair of herniated rectum into vaginal wall | 35 | $10,712 | $290 |
| Short return visit (20+ min) | 108 | $8,485 | $64 |
| Partial removal of uterus, tubes, and/or ovaries with retention of cervix using an endoscope, 250.0 g or less | 23 | $8,066 | $351 |
| Long return visit (40+ min) | 40 | $4,666 | $117 |
| Repair of prolapsing vaginal vault through vagina | 14 | $4,313 | $308 |
| Diagnostic exam of bladder and urethra using an endoscope | 24 | $3,453 | $144 |
| Repair of pelvic ligaments through vagina | 11 | $2,508 | $228 |
| New patient visit (45+ min) | 14 | $2,000 | $143 |
| Injection of drug or substance under skin or into muscle | 53 | $1,380 | $21 |
| Diagnostic exam of bladder and urethra using an endoscope | 18 | $746 | $41 |
2017: 23 services
| Insertion of lower leg neurostimulator electrode | 52 | $45,632 | $126 |
| Surgical repair of vaginal defect using an endoscope | 44 | $36,914 | $839 |
| Botox | 42 | $32,763 | None |
| Short return visit (20+ min) | 191 | $20,019 | $64 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 41 | $17,485 | $296 |
| Creation of sling around urethra in female to control leakage | 37 | $14,862 | $402 |
| New patient visit (30+ min) | 151 | $13,486 | $89 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 20 | $12,324 | $616 |
| Repair of herniated rectum into vaginal wall | 31 | $10,939 | $353 |
| Insertion of temporary bladder tube | 197 | $10,474 | $43 |
| Return visit (30+ min) | 65 | $7,478 | $100 |
| Partial removal of uterus, tubes, and/or ovaries with retention of cervix using an endoscope, 250.0 g or less | 21 | $7,386 | $352 |
| Insertion of sacral nerve neurostimulator electrode | 11 | $6,439 | $585 |
| Repair of prolapsing vaginal vault through vagina | 12 | $3,714 | $310 |
| New patient visit (45+ min) | 24 | $3,574 | $149 |
| Diagnostic exam of bladder and urethra using an endoscope | 42 | $2,059 | $49 |
| Diagnostic exam of bladder and urethra using an endoscope | 15 | $2,024 | $135 |
| Simple bladder irrigation and/or instillation | 24 | $1,779 | $57 |
| Short return visit | 31 | $1,221 | $37 |
| Fitting and insertion of vaginal support device | 13 | $988 | $71 |
| Pessary, reusable, non rubber, any type | 12 | $564 | $43 |
| Injection of drug or substance under skin or into muscle | 19 | $542 | $26 |
| Electronic assessment of bladder emptying | 15 | $115 | $8 |
2016: 21 services
| Insertion of lower leg neurostimulator electrode | 28 | $25,986 | $130 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 38 | $24,166 | $636 |
| Short return visit (20+ min) | 191 | $22,671 | $65 |
| Surgical repair of vaginal defect using an endoscope | 19 | $16,337 | $860 |
| New patient visit (30+ min) | 166 | $15,101 | $91 |
| Insertion of temporary bladder tube | 186 | $11,282 | $52 |
| Creation of sling around urethra in female to control leakage | 24 | $9,240 | $385 |
| Botox | 18 | $8,322 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 19 | $7,229 | $301 |
| Repair of herniated rectum into vaginal wall | 17 | $6,656 | $370 |
| Removal of uterus through vagina, 250.0 g or less | 17 | $5,880 | $346 |
| Repair of prolapsing vaginal vault through vagina | 18 | $5,540 | $308 |
| Repair of pelvic ligaments through vagina | 13 | $2,954 | $227 |
| Short return visit | 59 | $2,728 | $36 |
| Diagnostic exam of bladder and urethra using an endoscope | 39 | $2,343 | $60 |
| New patient visit (45+ min) | 17 | $1,978 | $116 |
| Fitting and insertion of vaginal support device | 22 | $1,383 | $58 |
| New patient visit (15+ min) | 18 | $1,199 | $67 |
| Simple bladder irrigation and/or instillation | 11 | $802 | $67 |
| Pessary, reusable, non rubber, any type | 12 | $517 | $43 |
| Injection of drug or substance under skin or into muscle | 11 | $304 | $25 |
2015: 18 services
| Short return visit (20+ min) | 110 | $16,538 | $70 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 21 | $15,193 | $723 |
| Creation of sling around urethra in female to control leakage | 29 | $13,715 | $473 |
| New patient visit (30+ min) | 123 | $12,506 | $102 |
| Insertion of temporary bladder tube | 158 | $11,554 | $54 |
| Insertion of lower leg neurostimulator electrode | 15 | $6,943 | $114 |
| Removal of uterus through vagina, 250.0 g or less | 16 | $6,437 | $402 |
| Fitting and insertion of vaginal support device | 30 | $4,746 | $69 |
| Repair of prolapsing vaginal vault through vagina | 12 | $3,887 | $324 |
| Return visit (30+ min) | 31 | $3,709 | $98 |
| New patient visit (45+ min) | 23 | $3,210 | $140 |
| Short return visit | 39 | $2,626 | $41 |
| Simple bladder irrigation and/or instillation | 26 | $2,521 | $79 |
| Pessary, reusable, non rubber, any type | 17 | $908 | $43 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $838 | $60 |
| New patient visit (15+ min) | 12 | $804 | $67 |
| Ultrasound measurement of bladder capacity after voiding | 16 | $327 | $19 |
| Electronic assessment of bladder emptying | 11 | $87 | $8 |
2014: 16 services
| Insertion of lower leg neurostimulator electrode | 14 | $14,218 | $120 |
| Short return visit (20+ min) | 96 | $13,027 | $64 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 19 | $12,965 | $682 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 31 | $10,177 | $328 |
| Creation of sling around urethra in female to control leakage | 15 | $7,034 | $469 |
| Insertion of temporary bladder tube | 67 | $4,443 | $50 |
| Repair of prolapsing vaginal vault through vagina | 13 | $4,339 | $334 |
| New patient visit (45+ min) | 26 | $3,783 | $145 |
| Fitting and insertion of vaginal support device | 22 | $3,342 | $71 |
| New patient visit (30+ min) | 34 | $2,977 | $88 |
| Short return visit | 41 | $2,668 | $40 |
| Return visit (30+ min) | 23 | $2,263 | $98 |
| Insertion of device into abdomen with pressure and urine flow rate study | 17 | $1,845 | $109 |
| Long return visit (40+ min) | 13 | $1,711 | $132 |
| Diagnostic exam of bladder and urethra using an endoscope | 20 | $1,188 | $59 |
| Electronic assessment of bladder emptying | 34 | $249 | $7 |
2013: 3 services
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 11 | $3,532 | $321 |
| Short return visit (20+ min) | 33 | $3,303 | $61 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $1,178 | $107 |
Drugs they prescribed that Part D paid
$427,608
Pharmacies billed $427,608 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (70 of 1,335) in 2024. Above the middle of the specialty; the typical undefined physician type clinician is at 0%.
775 generic and fewer than 11 brand-name prescriptions · $427,608 in drug cost · 419 antibiotic prescriptions to 226 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 248 | $277,426 | $1,119 |
| Myrbetriq | 83 | $62,468 | $753 |
| Premarin | 120 | $51,450 | $429 |
| Estring | 26 | $13,391 | $515 |
| Estradiol | 184 | $11,729 | $64 |
See all 15 drugs
| Gemtesa | 248 | $277,426 | $1,119 |
| Myrbetriq | 83 | $62,468 | $753 |
| Premarin | 120 | $51,450 | $429 |
| Estring | 26 | $13,391 | $515 |
| Estradiol | 184 | $11,729 | $64 |
| Yuvafem | 11 | $2,138 | $194 |
| Nitrofurantoin Mono-Macro | 231 | $1,740 | $8 |
| Methenamine Hippurate | 23 | $1,195 | $52 |
| Ibuprofen | 70 | $509 | $7 |
| Hydrocodone-Acetaminophen | 68 | $446 | $7 |
| Cephalexin | 64 | $301 | $5 |
| Desmopressin Acetate | 11 | $237 | $22 |
| Sulfamethoxazole-Trimethoprim | 70 | $153 | $2 |
| Ciprofloxacin | 28 | $115 | $4 |
| Fluconazole | 11 | $50 | $5 |
Year by year
| 2024 | 1,335 | 537 | 5% (70) | None | $427,608 |
| 2023 | 1,403 | 510 | 5% (63) | None | $449,333 |
| 2022 | 847 | 350 | None | 50% | $216,209 |
| 2021 | 844 | 328 | 3% (23) | 51% | $209,748 |
| 2020 | 823 | 324 | 1% (11) | 58% | $240,507 |
| 2019 | 1,093 | 374 | 3% (33) | 54% | $271,374 |
| 2018 | 931 | 322 | None | 56% | $239,109 |
| 2017 | 887 | 262 | None | 60% | $221,019 |
| 2016 | 685 | 221 | None | 62% | $145,271 |
| 2015 | 494 | 151 | None | 53% | $78,378 |
| 2014 | 334 | 102 | 6% (21) | 55% | $49,620 |
| 2013 | 149 | 42 | None | 58% | $19,321 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Gemtesa | 204 | $222,896 | $1,093 |
| Myrbetriq | 105 | $102,186 | $973 |
| Premarin | 173 | $78,078 | $451 |
| Estring | 38 | $20,280 | $534 |
| Estradiol | 91 | $9,642 | $106 |
| Nitrofurantoin Mono-Macro | 285 | $2,816 | $10 |
| Methenamine Hippurate | 21 | $2,405 | $115 |
| Nitrofurantoin | 20 | $1,868 | $93 |
| Ibuprofen | 62 | $816 | $13 |
| Hydrocodone-Acetaminophen | 57 | $389 | $7 |
| Cephalexin | 63 | $360 | $6 |
| Sulfamethoxazole-Trimethoprim | 93 | $287 | $3 |
| Metronidazole | 32 | $267 | $8 |
| Ciprofloxacin | 41 | $164 | $4 |
| Fluconazole | 16 | $97 | $6 |
2022: 13 drugs
| Myrbetriq | 91 | $71,981 | $791 |
| Premarin | 146 | $63,124 | $432 |
| Gemtesa | 32 | $38,511 | $1,203 |
| Estring | 28 | $14,604 | $522 |
| Estradiol | 83 | $9,424 | $114 |
| Methenamine Hippurate | 24 | $2,789 | $116 |
| Nitrofurantoin Mono-Macro | 225 | $2,711 | $12 |
| Yuvafem | 11 | $2,379 | $216 |
| Nitrofurantoin | 14 | $1,052 | $75 |
| Cephalexin | 39 | $230 | $6 |
| Sulfamethoxazole-Trimethoprim | 50 | $230 | $5 |
| Fluconazole | 11 | $93 | $8 |
| Ciprofloxacin | 24 | $80 | $3 |
2021: 17 drugs
| Myrbetriq | 149 | $107,933 | $724 |
| Premarin | 140 | $58,033 | $415 |
| Toviaz | 20 | $12,205 | $610 |
| Estring | 19 | $9,091 | $478 |
| Estradiol | 53 | $7,313 | $138 |
| Methenamine Hippurate | 37 | $4,645 | $126 |
| Nitrofurantoin | 25 | $2,341 | $94 |
| Nitrofurantoin Mono-Macro | 174 | $1,995 | $11 |
| Oxybutynin Chloride Er | 14 | $746 | $53 |
| Metronidazole | 18 | $337 | $19 |
| Ibuprofen | 19 | $182 | $10 |
| Sulfamethoxazole-Trimethoprim | 50 | $148 | $3 |
| Hydrocodone-Acetaminophen | 11 | $113 | $10 |
| Cephalexin | 22 | $101 | $5 |
| Fluconazole | 12 | $68 | $6 |
| Ciprofloxacin | 20 | $48 | $2 |
| Oxycodone | 11 | $45 | $4 |
2020: 13 drugs
| Myrbetriq | 181 | $123,855 | $684 |
| Premarin | 188 | $74,844 | $398 |
| Estradiol | 48 | $8,312 | $173 |
| Estring | 17 | $7,817 | $460 |
| Methenamine Hippurate | 49 | $6,052 | $124 |
| Estrace | 17 | $6,046 | $356 |
| Nitrofurantoin | 25 | $1,931 | $77 |
| Nitrofurantoin Mono-Macro | 121 | $1,276 | $11 |
| Oxybutynin Chloride Er | 16 | $1,191 | $74 |
| Cephalexin | 24 | $186 | $8 |
| Ciprofloxacin | 19 | $134 | $7 |
| Sulfamethoxazole-Trimethoprim | 27 | $86 | $3 |
| Fluconazole | 13 | $68 | $5 |
2019: 19 drugs
| Myrbetriq | 165 | $107,420 | $651 |
| Premarin | 232 | $89,608 | $386 |
| Vesicare | 37 | $18,877 | $510 |
| Estradiol | 62 | $12,288 | $198 |
| Estrace | 33 | $11,459 | $347 |
| Estring | 13 | $5,847 | $450 |
| Tolterodine Tartrate Er | 18 | $3,738 | $208 |
| Nitrofurantoin Mono-Macro | 172 | $1,828 | $11 |
| Methenamine Hippurate | 12 | $1,794 | $150 |
| Oxybutynin Chloride Er | 27 | $1,469 | $54 |
| Nitrofurantoin | 27 | $1,446 | $54 |
| Solifenacin | 14 | $1,280 | $91 |
| Ibuprofen | 28 | $230 | $8 |
| Sulfamethoxazole-Trimethoprim | 76 | $217 | $3 |
| Cephalexin | 32 | $186 | $6 |
| Amitriptyline | 24 | $152 | $6 |
| Ciprofloxacin | 29 | $146 | $5 |
| Oxycodone | 20 | $109 | $5 |
| Hydrocodone-Acetaminophen | 11 | $56 | $5 |
2018: 16 drugs
| Myrbetriq | 193 | $102,059 | $529 |
| Premarin | 143 | $52,392 | $366 |
| Vesicare | 80 | $34,397 | $430 |
| Estrace | 42 | $14,566 | $347 |
| Estradiol | 46 | $10,461 | $227 |
| Estring | 13 | $5,591 | $430 |
| Tolterodine Tartrate Er | 30 | $3,883 | $129 |
| Oxybutynin Chloride Er | 28 | $1,866 | $67 |
| Nitrofurantoin | 20 | $1,113 | $56 |
| Nitrofurantoin Mono-Macro | 81 | $995 | $12 |
| Cephalexin | 68 | $250 | $4 |
| Ciprofloxacin | 35 | $201 | $6 |
| Metronidazole | 11 | $190 | $17 |
| Sulfamethoxazole-Trimethoprim | 43 | $135 | $3 |
| Fluconazole | 12 | $50 | $4 |
| Amitriptyline | 12 | $6 | $1 |
2017: 12 drugs
| Myrbetriq | 258 | $110,643 | $429 |
| Premarin | 114 | $39,435 | $346 |
| Vesicare | 96 | $36,749 | $383 |
| Estrace | 50 | $15,064 | $301 |
| Estring | 13 | $4,856 | $374 |
| Nitrofurantoin Mono-Macro | 70 | $1,363 | $19 |
| Oxybutynin Chloride Er | 11 | $755 | $69 |
| Ciprofloxacin | 48 | $293 | $6 |
| Cephalexin | 56 | $222 | $4 |
| Metronidazole | 14 | $187 | $13 |
| Sulfamethoxazole-Trimethoprim | 47 | $159 | $3 |
| Fluconazole | 11 | $62 | $6 |
2016: 11 drugs
| Myrbetriq | 167 | $60,896 | $365 |
| Premarin | 135 | $41,179 | $305 |
| Vesicare | 56 | $17,885 | $319 |
| Estrace | 30 | $7,981 | $266 |
| Nitrofurantoin Mono-Macro | 74 | $2,396 | $32 |
| Nitrofurantoin | 15 | $824 | $55 |
| Oxybutynin Chloride Er | 14 | $694 | $50 |
| Metronidazole | 21 | $517 | $25 |
| Bethanechol Chloride | 15 | $450 | $30 |
| Ciprofloxacin | 30 | $233 | $8 |
| Sulfamethoxazole-Trimethoprim | 36 | $140 | $4 |
2015: 11 drugs
| Premarin | 126 | $33,249 | $264 |
| Myrbetriq | 64 | $20,986 | $328 |
| Vesicare | 31 | $11,671 | $376 |
| Estrace | 15 | $3,104 | $207 |
| Nitrofurantoin Mono-Macro | 53 | $1,343 | $25 |
| Bethanechol Chloride | 11 | $346 | $31 |
| Metronidazole | 23 | $268 | $12 |
| Ciprofloxacin | 22 | $198 | $9 |
| Ibuprofen | 20 | $157 | $8 |
| Fluconazole | 15 | $119 | $8 |
| Sulfamethoxazole-Trimethoprim | 28 | $114 | $4 |
2014: 9 drugs
| Premarin | 92 | $20,192 | $219 |
| Myrbetriq | 51 | $15,176 | $298 |
| Vesicare | 25 | $6,835 | $273 |
| Oxybutynin Chloride Er | 23 | $1,357 | $59 |
| Nitrofurantoin Mono-Macro | 26 | $873 | $34 |
| Hydrocodone-Acetaminophen | 20 | $167 | $8 |
| Ciprofloxacin | 13 | $99 | $8 |
| Ibuprofen | 15 | $84 | $6 |
| Sulfamethoxazole-Trimethoprim | 19 | $76 | $4 |
2013: 3 drugs
| Vesicare | 31 | $6,280 | $203 |
| Premarin | 31 | $5,826 | $188 |
| Oxybutynin Chloride Er | 22 | $915 | $42 |
Money from drug and device companies
$79,221 in 2025
| 2025 | 6 | 100 | $69,793 | $79,221 |
| 2024 | 7 | 86 | $45,430 | $52,854 |
| 2023 | 7 | 69 | $40,033 | $47,297 |
| 2022 | 7 | 68 | $38,030 | $44,757 |
| 2021 | 7 | 26 | $7,070 | $9,091 |
| 2020 | 2 | 2 | None | $162 |
| 2019 | 4 | 24 | $2,488 | $9,461 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Advantage System | $28,942 | 36 payments
|
| Sumitomo Pharma America | Gemtesa | $27,243 | 25 payments
|
| Abbvie | Botox | $14,436 | 24 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $5,159 | 8 payments
|
| Medtronic | Interstim | $3,411 | 6 payments
|
| Bluewind Medical | Revi | $31 | 1 payment
|
See all 100 published payments
| Boston Scientific | Paid to speak or teach · 2025-12-24 | Advantage System | $6,800 |
| Boston Scientific | Paid to speak or teach · 2025-12-24 | Advantage System | $2,550 |
| Boston Scientific | Travel · 2025-12-24 | Advantage System | $87 |
| Sumitomo Pharma America | Paid to speak or teach · 2025-12-22 | Gemtesa | $6,375 |
| Sumitomo Pharma America | Paid to speak or teach · 2025-12-22 | Gemtesa | $6,375 |
| Sumitomo Pharma America | Meals · 2025-12-19 | Gemtesa | $9 |
| Sumitomo Pharma America | Travel · 2025-12-19 | Gemtesa | $214 |
| Abbvie | Meals · 2025-12-19 | Botox | $4 |
| Sumitomo Pharma America | Meals · 2025-12-18 | Gemtesa | $41 |
| Sumitomo Pharma America | Travel · 2025-12-18 | Gemtesa | $110 |
| Sumitomo Pharma America | Meals · 2025-12-17 | Gemtesa | $125 |
| Sumitomo Pharma America | Travel · 2025-12-15 | Gemtesa | $784 |
| Sumitomo Pharma America | Meals · 2025-12-11 | Gemtesa | $97 |
| Sumitomo Pharma America | Travel · 2025-12-11 | Gemtesa | $324 |
| Sumitomo Pharma America | Paid to speak or teach · 2025-12-10 | Gemtesa | $6,375 |
| Sumitomo Pharma America | Meals · 2025-12-10 | Gemtesa | $125 |
| Intuitive Surgical | Paid to speak or teach · 2025-12-10 | Da Vinci Surgical System | $2,000 |
| Intuitive Surgical | Meals · 2025-12-10 | Da Vinci Surgical System | $150 |
| Intuitive Surgical | Paid to speak or teach · 2025-12-10 | Da Vinci Surgical System | $500 |
| Sumitomo Pharma America | Travel · 2025-12-09 | Gemtesa | $175 |
| Sumitomo Pharma America | Meals · 2025-12-08 | Gemtesa | $31 |
| Intuitive Surgical | Paid to speak or teach · 2025-12-05 | Da Vinci Surgical System | $500 |
| Sumitomo Pharma America | Travel · 2025-11-20 | Gemtesa | $476 |
| Sumitomo Pharma America | Travel · 2025-11-20 | Gemtesa | $234 |
| Abbvie | Meals · 2025-11-18 | Botox | $4 |
| Intuitive Surgical | Meals · 2025-11-11 | Da Vinci Surgical System | $9 |
| Sumitomo Pharma America | Meals · 2025-11-10 | Gemtesa | $16 |
| Sumitomo Pharma America | Travel · 2025-11-10 | Gemtesa | $271 |
| Medtronic | Travel · 2025-11-09 | Altaviva | $33 |
| Medtronic | Travel · 2025-11-07 | Altaviva | $19 |
| Sumitomo Pharma America | Meals · 2025-11-05 | Gemtesa | $145 |
| Medtronic | Travel · 2025-11-03 | Altaviva | $693 |
| Medtronic | Travel · 2025-11-03 | Altaviva | $35 |
| Sumitomo Pharma America | Travel · 2025-10-15 | Gemtesa | $198 |
| Sumitomo Pharma America | Meals · 2025-10-07 | Gemtesa | $90 |
| Boston Scientific | Meals · 2025-10-04 | Axonics | $137 |
| Sumitomo Pharma America | Paid to speak or teach · 2025-09-30 | Gemtesa | $2,625 |
| Sumitomo Pharma America | Meals · 2025-09-25 | Gemtesa | $123 |
| Boston Scientific | Paid to speak or teach · 2025-09-04 | Advantage System | $213 |
| Boston Scientific | Meals · 2025-09-03 | Bulkamid | $70 |
| Sumitomo Pharma America | Meals · 2025-08-27 | Gemtesa | $32 |
| Sumitomo Pharma America | Paid to speak or teach · 2025-08-13 | Gemtesa | $1,875 |
| Boston Scientific | Paid to speak or teach · 2025-08-07 | General - Therapies | $1,488 |
| Boston Scientific | Paid to speak or teach · 2025-08-07 | General - Therapies | $425 |
| Boston Scientific | Meals · 2025-06-26 | Axonics | $103 |
| Boston Scientific | Meals · 2025-06-18 | Axonics | $107 |
| Boston Scientific | Meals · 2025-06-17 | Axonics | $49 |
| Boston Scientific | Meals · 2025-06-12 | Axonics | $16 |
| Abbvie | Meals · 2025-06-03 | Botox | $25 |
| Abbvie | Meals · 2025-05-20 | None | $78 |
| Abbvie | Paid to speak or teach · 2025-05-16 | Botox | $3,325 |
| Bluewind Medical | Meals · 2025-05-16 | Revi | $31 |
| Boston Scientific | Meals · 2025-05-08 | General - Therapies | $93 |
| Boston Scientific | Paid to speak or teach · 2025-05-01 | General - Female Sui | $425 |
| Boston Scientific | Paid to speak or teach · 2025-05-01 | General - Female Sui | $2,975 |
| Boston Scientific | Paid to speak or teach · 2025-05-01 | General - Female Sui | $1,275 |
| Abbvie | Meals · 2025-04-24 | Botox | $122 |
| Abbvie | Travel · 2025-04-24 | Botox | $314 |
| Abbvie | Travel · 2025-04-24 | Botox | $16 |
| Medtronic | Paid to speak or teach · 2025-04-24 | Interstim | $2,500 |
| Medtronic | Meals · 2025-04-16 | Interstim | $131 |
| Abbvie | Paid to speak or teach · 2025-04-11 | Botox | $2,613 |
| Boston Scientific | Paid to speak or teach · 2025-04-10 | General - Female Sui | $1,063 |
| Boston Scientific | Paid to speak or teach · 2025-04-10 | General - Female Sui | $850 |
| Abbvie | Paid to speak or teach · 2025-04-02 | Botox | $2,375 |
| Boston Scientific | Meals · 2025-04-01 | Axonics | $34 |
| Boston Scientific | Meals · 2025-04-01 | Axonics | $42 |
| Abbvie | Meals · 2025-03-22 | Botox | $21 |
| Abbvie | Meals · 2025-03-22 | Botox | $60 |
| Abbvie | Travel · 2025-03-22 | Botox | $333 |
| Abbvie | Meals · 2025-03-22 | Botox | $50 |
| Abbvie | Travel · 2025-03-22 | Botox | $842 |
| Abbvie | Meals · 2025-03-21 | Botox | $150 |
| Abbvie | Travel · 2025-03-21 | Botox | $172 |
| Boston Scientific | Meals · 2025-03-20 | Axonics | $15 |
| Boston Scientific | Meals · 2025-03-20 | Axonics | $22 |
| Abbvie | Meals · 2025-03-18 | Botox | $125 |
| Abbvie | Travel · 2025-03-18 | Botox | $73 |
| Abbvie | Travel · 2025-03-18 | Botox | $18 |
| Intuitive Surgical | Paid to speak or teach · 2025-03-07 | Da Vinci Surgical System | $1,000 |
| Boston Scientific | Paid to speak or teach · 2025-02-27 | General - Therapies | $425 |
| Boston Scientific | Paid to speak or teach · 2025-02-27 | General - Therapies | $893 |
| Boston Scientific | Paid to speak or teach · 2025-02-27 | General - Therapies | $850 |
| Abbvie | Paid to speak or teach · 2025-02-26 | Botox | $3,325 |
| Boston Scientific | Travel · 2025-02-20 | Upsylon | $252 |
| Boston Scientific | Paid to speak or teach · 2025-02-20 | Upsylon | $3,400 |
| Boston Scientific | Paid to speak or teach · 2025-02-20 | Upsylon | $850 |
| Boston Scientific | Travel · 2025-02-20 | Upsylon | $113 |
| Boston Scientific | Paid to speak or teach · 2025-02-20 | Upsylon | $2,550 |
| Boston Scientific | Meals · 2025-02-20 | Solyx Sis System | $40 |
| Boston Scientific | Meals · 2025-02-20 | Solyx Sis System | $3 |
| Abbvie | Travel · 2025-02-04 | Botox | $244 |
| Abbvie | Meals · 2025-02-04 | Botox | $125 |
| Abbvie | Meals · 2025-01-31 | Botox | $24 |
| Intuitive Surgical | Paid to speak or teach · 2025-01-17 | Da Vinci Surgical System | $500 |
| Boston Scientific | Meals · 2025-01-16 | Axonics | $30 |
| Intuitive Surgical | Paid to speak or teach · 2025-01-10 | Da Vinci Surgical System | $500 |
| Boston Scientific | Travel · 2025-01-08 | Upsylon | $300 |
| Boston Scientific | Travel · 2025-01-08 | Upsylon | $112 |
| Boston Scientific | Travel · 2025-01-07 | Upsylon | $285 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $52,854
| Boston Scientific | Advantage System | $19,240 | 26 payments
|
| Medtronic | Interstim | $15,456 | 24 payments
|
| Abbvie | Botox | $15,377 | 14 payments
|
| Axonics | Axonics | $2,290 | 17 payments
|
| Caldera Medical | Desara | $442 | 2 payments
|
| Valencia Technologies | Ecoin Device Kit | $36 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $13 | 1 payment
|
2023: $47,297
| Medtronic | Interstim | $40,039 | 55 payments
|
| Boston Scientific | Upsylon | $4,789 | 6 payments
|
| Valencia Technologies | Ecoin Device Kit | $996 | 1 payment
|
| Intuitive Surgical | Da Vinci Sp | $564 | 3 payments
|
| Applied Medical Resources | Gelpoint V-Path | $480 | 2 payments
|
| Abbvie | Botox | $400 | 1 payment
|
| Caldera Medical | Desara | $29 | 1 payment
|
2022: $44,757
| Medtronic | Interstim | $40,771 | 62 payments
|
| Boston Scientific | Upsylon | $2,880 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $500 | 1 payment
|
| Valencia Technologies | Ecoin Device Kit | $483 | 1 payment
|
| Astellas Pharma US | None | $80 | 1 payment
|
| Applied Medical Resources | Gelpoint V-Path | $26 | 1 payment
|
| Rochester Medical | None | $18 | 1 payment
|
2021: $9,091
| Medtronic | Interstim | $5,502 | 18 payments
|
| Boston Scientific | Colpassist | $2,602 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $500 | 1 payment
|
| Axonics | Axonics R-Snm System | $283 | 2 payments
|
| Astellas Pharma US | None | $100 | 1 payment
|
| Coloplast | Restorelle | $62 | 1 payment
|
| Stryker | Iris | $42 | 1 payment
|
2020: $162
| Coloplast | Altis | $149 | 1 payment
|
| Medtronic USA | Interstim | $13 | 1 payment
|
2019: $9,461
| Intuitive Surgical | Da Vinci Surgical System | $5,381 | 8 payments
|
| Boston Scientific | Advantage | $2,422 | 4 payments
|
| Coloplast | Altis | $1,222 | 10 payments
|
| Allergan | Botox | $436 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Medtronic, Inc. · 2021 | This clinician | $315 |
Professional record
- NPI
- 1447323092
- Licence
- CA A71453California A71453: Current · expires 2027-06-30
- Trained
- University of Michigan Medical School, 1996
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VF0040X (207VF0040X); Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 2350 W. El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-11-15
- NPI last updated
- 2015-08-14
This is when the NPI record was last certified, not a medical board exam.